Literature DB >> 10590064

Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.

R M Egeler1, B E Favara, M van Meurs, J D Laman, E Claassen.   

Abstract

The pathogenesis of Langerhans cell histiocytosis (LCH) remains poorly understood. To further elucidate LCH pathogenesis, we analyzed the expression of 10 cytokines relevant to cellular recruitment and activation at the protein level in 14 patients and identified the lesional cells responsible for cytokine production in situ by immunohistochemistry. The cytokines investigated included the hematopoietic growth factors interleukin-3 (IL-3), IL-7, and granulocyte-macrophage colony-stimulating factor (GM-CSF); the lymphocyte regulatory cytokines IL-2, IL-4, and IL-10; the inflammatory regulators IL-1alpha and tumor necrosis factor-alpha (TNF-alpha); and the effector cell-activating cytokines IL-5 and interferon-gamma (IFN-gamma). In all specimens, CD1a(+) histiocytes (LCH cells) and CD3(+) T cells produced large amounts of cytokines, creating a true cytokine storm. IL-2, IL-4, IL-5, and TNF-alpha were produced exclusively by T cells, whereas only IL-1alpha was produced by LCH cells. Equal numbers of LCH cells, T cells, and macrophages produced GM-CSF and IFN-gamma. Equal numbers of LCH cells and macrophages produced IL-10, whereas IL-3 was produced by T cells and macrophages. IL-7 was only produced by macrophages. Eosinophils, present in some specimens, were partially responsible for the production of IL-5, IFN-gamma, GM-CSF, IL-10, IL-3, and IL-7. Expression of all cytokines, abundant in most biopsies, was irrespective of age, gender, or site of biopsy. These findings emphasize the role of T cells in LCH. The juxtaposition of T cells and LCH cells suggests that both cells interact in a cytokine amplification cascade, resulting from stimulation of autocrine and paracrine stimulatory loops. This cascade can be linked directly to the development of LCH through recruitment, maturation, and proliferation of LCH cells. The cytokines studied are known to be involved in the development of other characteristic features of LCH, such as fibrosis, necrosis, and osteolysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10590064

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

1.  Squash smear cytology of Langerhans cell histiocytosis.

Authors:  Ji Hae Nahm; Gun Yoon; Sung-Im Do; Hyun-Soo Kim
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 2.  [Pulmonary Langerhans cell histiocytosis].

Authors:  H H Popper
Journal:  Pathologe       Date:  2015-09       Impact factor: 1.011

3.  Paediatric neuroradiological aspects of Langerhans cell histiocytosis.

Authors:  Philippe Demaerel; Stefaan Van Gool
Journal:  Neuroradiology       Date:  2007-11-06       Impact factor: 2.804

4.  Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.

Authors:  Huai-Chia Chuang; Jong-Ding Lay; Shuang-En Chuang; Wen-Chuan Hsieh; Yao Chang; Ih-Jen Su
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 5.  Langerhans cell histiocytosis presenting as hypothyroid goitre: a unique presentation.

Authors:  Krishna Chaitanya Marupudi; Suman S Karanth; Joseph Thomas
Journal:  BMJ Case Rep       Date:  2014-12-02

6.  IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy.

Authors:  Ichiro Murakami; Akira Morimoto; Takashi Oka; Satoshi Kuwamoto; Masako Kato; Yasushi Horie; Kazuhiko Hayashi; Jean Gogusev; Francis Jaubert; Shinsaku Imashuku; Lamia Abd Al-Kadar; Katsuyoshi Takata; Tadashi Yoshino
Journal:  Virchows Arch       Date:  2012-12-27       Impact factor: 4.064

7.  Multisystemic Langerhans cell histiocytosis with advanced lung involvement.

Authors:  Ricardo Andrade Fernandes de Mello; Joana Waked Tanos; Melissa Bozzi Nonato Mello; Edson Marchiori
Journal:  J Radiol Case Rep       Date:  2012-11-01

8.  A 36-year-old man with seizures and multiple cystic pulmonary nodules.

Authors:  Megan L Krause; Richard K Patch; Sean M Caples
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

9.  New insights into the molecular pathogenesis of langerhans cell histiocytosis.

Authors:  Francesca M Rizzo; Mauro Cives; Valeria Simone; Franco Silvestris
Journal:  Oncologist       Date:  2014-01-16

Review 10.  Juvenile xanthogranuloma developing after treatment of Langerhans cell histiocytosis: case report and literature review.

Authors:  Johanna D Strehl; Klaus-Daniel Stachel; Arndt Hartmann; Abbas Agaimy
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.